278 related articles for article (PubMed ID: 32735933)
1. Synthesis of PLGA/chitosan/zeolites and PLGA/chitosan/metal organic frameworks nanofibers for targeted delivery of Paclitaxel toward prostate cancer cells death.
Faraji Dizaji B; Hasani Azerbaijan M; Sheisi N; Goleij P; Mirmajidi T; Chogan F; Irani M; Sharafian F
Int J Biol Macromol; 2020 Dec; 164():1461-1474. PubMed ID: 32735933
[TBL] [Abstract][Full Text] [Related]
2. Incorporation of magnetic NaX zeolite/DOX into the PLA/chitosan nanofibers for sustained release of doxorubicin against carcinoma cells death in vitro.
Abasian P; Radmansouri M; Habibi Jouybari M; Ghasemi MV; Mohammadi A; Irani M; Jazi FS
Int J Biol Macromol; 2019 Jan; 121():398-406. PubMed ID: 30287373
[TBL] [Abstract][Full Text] [Related]
3. UiO-66 metal organic framework nanoparticles loaded carboxymethyl chitosan/poly ethylene oxide/polyurethane core-shell nanofibers for controlled release of doxorubicin and folic acid.
Farboudi A; Mahboobnia K; Chogan F; Karimi M; Askari A; Banihashem S; Davaran S; Irani M
Int J Biol Macromol; 2020 May; 150():178-188. PubMed ID: 32045607
[TBL] [Abstract][Full Text] [Related]
4. Fabrication of poly(acrylic acid) grafted-chitosan/polyurethane/magnetic MIL-53 metal organic framework composite core-shell nanofibers for co-delivery of temozolomide and paclitaxel against glioblastoma cancer cells.
Bazzazzadeh A; Dizaji BF; Kianinejad N; Nouri A; Irani M
Int J Pharm; 2020 Sep; 587():119674. PubMed ID: 32707243
[TBL] [Abstract][Full Text] [Related]
5. Electrospun micro- and nanofibers for sustained delivery of paclitaxel to treat C6 glioma in vitro.
Xie J; Wang CH
Pharm Res; 2006 Aug; 23(8):1817-26. PubMed ID: 16841195
[TBL] [Abstract][Full Text] [Related]
6. Magnetic bioactive glasses/Cisplatin loaded-chitosan (CS)-grafted- poly (ε-caprolactone) nanofibers against bone cancer treatment.
Amini Z; Rudsary SS; Shahraeini SS; Dizaji BF; Goleij P; Bakhtiari A; Irani M; Sharifianjazi F
Carbohydr Polym; 2021 Apr; 258():117680. PubMed ID: 33593554
[TBL] [Abstract][Full Text] [Related]
7. Fabrication of novel chitosan/PAN/magnetic ZSM-5 zeolite coated sponges for absorption of oil from water surfaces.
Samadi S; Yazd SS; Abdoli H; Jafari P; Aliabadi M
Int J Biol Macromol; 2017 Dec; 105(Pt 1):370-376. PubMed ID: 28705506
[TBL] [Abstract][Full Text] [Related]
8. Synthesis of magnetic gold coated poly (ε-caprolactonediol) based polyurethane/poly(N-isopropylacrylamide)-grafted-chitosan core-shell nanofibers for controlled release of paclitaxel and 5-FU.
Farboudi A; Nouri A; Shirinzad S; Sojoudi P; Davaran S; Akrami M; Irani M
Int J Biol Macromol; 2020 May; 150():1130-1140. PubMed ID: 31705906
[TBL] [Abstract][Full Text] [Related]
9. Long circulating chitosan/PEG blended PLGA nanoparticle for tumor drug delivery.
Parveen S; Sahoo SK
Eur J Pharmacol; 2011 Nov; 670(2-3):372-83. PubMed ID: 21951969
[TBL] [Abstract][Full Text] [Related]
10. In vitro-in vivo evaluation of chitosan-PLGA nanoparticles for potentiated gastric retention and anti-ulcer activity of diosmin.
Abd El Hady WE; Mohamed EA; Soliman OAE; El-Sabbagh HM
Int J Nanomedicine; 2019; 14():7191-7213. PubMed ID: 31564873
[TBL] [Abstract][Full Text] [Related]
11. PLGA Microparticles Entrapping Chitosan-Based Nanoparticles for the Ocular Delivery of Ranibizumab.
Elsaid N; Jackson TL; Elsaid Z; Alqathama A; Somavarapu S
Mol Pharm; 2016 Sep; 13(9):2923-40. PubMed ID: 27286558
[TBL] [Abstract][Full Text] [Related]
12. Simultaneous controlled release of 5-FU, DOX and PTX from chitosan/PLA/5-FU/g-C3N4-DOX/g-C3N4-PTX triaxial nanofibers for breast cancer treatment in vitro.
Habibi Jouybari M; Hosseini S; Mahboobnia K; Boloursaz LA; Moradi M; Irani M
Colloids Surf B Biointerfaces; 2019 Jul; 179():495-504. PubMed ID: 31005745
[TBL] [Abstract][Full Text] [Related]
13. Comparison and process optimization of PLGA, chitosan and silica nanoparticles for potential oral vaccine delivery.
Amin MK; Boateng JS
Ther Deliv; 2019 Aug; 10(8):493-514. PubMed ID: 31496377
[No Abstract] [Full Text] [Related]
14. Poly-(Lactic-co-Glycolic) Acid Nanoparticles for Synergistic Delivery of Epirubicin and Paclitaxel to Human Lung Cancer Cells.
Sharma N; Kumari RM; Gupta N; Syed A; Bahkali AH; Nimesh S
Molecules; 2020 Sep; 25(18):. PubMed ID: 32947799
[TBL] [Abstract][Full Text] [Related]
15. In-vitro anti-cancer activity of organic template-free hierarchical M (Cu, Ni)-modified ZSM-5 zeolites synthesized using silica source waste material.
Jesudoss SK; Judith Vijaya J; Kaviyarasu K; Iyyappa Rajan P; Narayanan S; John Kennedy L
J Photochem Photobiol B; 2018 Sep; 186():178-188. PubMed ID: 30075423
[TBL] [Abstract][Full Text] [Related]
16. Tetrac-decorated chitosan-coated PLGA nanoparticles as a new platform for targeted delivery of SN38.
Alibolandi M; Amel Farzad S; Mohammadi M; Abnous K; Taghdisi SM; Kalalinia F; Ramezani M
Artif Cells Nanomed Biotechnol; 2018; 46(sup2):1003-1014. PubMed ID: 29806500
[TBL] [Abstract][Full Text] [Related]
17. Surface-modified PLGA nanoparticles with PEG/LA-chitosan for targeted delivery of arsenic trioxide for liver cancer treatment: Inhibition effects enhanced and side effects reduced.
Song X; Wang J; Xu Y; Shao H; Gu J
Colloids Surf B Biointerfaces; 2019 Aug; 180():110-117. PubMed ID: 31030022
[TBL] [Abstract][Full Text] [Related]
18. pH-responsive mesoporous ZSM-5 zeolites/chitosan core-shell nanodisks loaded with doxorubicin against osteosarcoma.
Yang F; Wen X; Ke QF; Xie XT; Guo YP
Mater Sci Eng C Mater Biol Appl; 2018 Apr; 85():142-153. PubMed ID: 29407142
[TBL] [Abstract][Full Text] [Related]
19. Enhanced apoptotic and anticancer potential of paclitaxel loaded biodegradable nanoparticles based on chitosan.
Gupta U; Sharma S; Khan I; Gothwal A; Sharma AK; Singh Y; Chourasia MK; Kumar V
Int J Biol Macromol; 2017 May; 98():810-819. PubMed ID: 28189791
[TBL] [Abstract][Full Text] [Related]
20. Combination of Paclitaxel and R-flurbiprofen loaded PLGA nanoparticles suppresses glioblastoma growth on systemic administration.
Caban-Toktas S; Sahin A; Lule S; Esendagli G; Vural I; Karlı Oguz K; Soylemezoglu F; Mut M; Dalkara T; Khan M; Capan Y
Int J Pharm; 2020 Mar; 578():119076. PubMed ID: 31988035
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
